MAvatar originates from the Centre for Personalised Medicine (CPMed) at Linköping University, Sweden. CPMed aims to develop methods for personalised medicine and drug discovery based on combining genome-wide, bioinformatics, experimental and clinical studies. We have shown the feasibility of this in publications in leading journals like Science Translational Medicine in 2014, 2015 and 2017. Because disease-associated genes are variably expressed in different cell types, single cell RNA sequencing plays an important role. CPMed integrates multi-disciplinary experts with clinicians, and has a wide collaborative network based on coordinating two EU projects. CPMed and MAvatar are directed by professor Mikael Benson, who is an MD with almost twenty years of translational high-throughput research. Danuta Gawel is chief senior scientist, responsible for bioinformatics tool development at MAvatar.